Loading
Life sciences · Journal article
Oral Oncology · September 19, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
BACKGROUND: There remains heterogeneity in the management of intermediate-risk factors following transoral robotic surgery (TORS) for oropharyngeal cancer (OPC). METHODS: A 23-item case-based survey assessing postoperative-management across risk factors following TORS for OPC was distributed to members of the American Head and Neck Society (AHNS). RESULTS: Sixty-four responses (4.5 % of members) were received, predominantly from U.S-based surgical oncologists (96.2 %), with most reporting ≥ 10 years in practice. Without additional pathological risk factors, observation was recommended for 98.4 % of cases with > 5 mm and 3 mm margins, decreasing to 79.7 % for 2 mm margins and 48.8 % for 1 mm margins. Positive deep margins prompted adjuvant therapy in 85.9 % of responses; however, when re-resection achieved negative margins, adjuvant treatment decreased to 20.3 %. For clear margins with four positive nodes and no extranodal extension, most respondents recommended adjuvant radiation to the neck alone (48.4 %). CONCLUSIONS: Adjuvant therapy decisions following TORS should involve multidisciplinary discussion including consideration of re-resection.